|
2018-09-04 |
2018-08-30 |
PS
Planned sale
|
Cole Gregory S
Chief Financial Officer
Officer
|
82,304
-55.6%
27.40
USD 2,255,492
|
82,304
-55.6%
|
27.40
|
USD 2,255,492
|
|
|
2018-08-17 |
2018-08-16 |
PS
Planned sale
|
Cole Gregory S
Chief Financial Officer
Officer
|
1,480
-2.2%
20.08
USD 29,715
|
1,480
-2.2%
|
20.08
|
USD 29,715
|
|
|
2018-08-17 |
2018-08-16 |
PS
Planned sale
|
MORATIS GEORGE Z
Global Accounting Officer
Officer
|
695
-3.0%
20.19
USD 14,035
|
695
-3.0%
|
20.19
|
USD 14,035
|
|
|
2018-07-06 |
2018-07-03 |
PS
Planned sale
|
Cole Gregory S
Chief Financial Officer
Officer
|
867
-1.3%
22.47
USD 19,482
|
867
-1.3%
|
22.47
|
USD 19,482
|
|
|
2018-06-08 |
2018-06-08 |
PS
Planned sale
|
MORATIS GEORGE Z
Global Accounting Officer
|
455
-2.2%
22.81
USD 10,378
|
455
-2.2%
|
22.81
|
USD 10,378
|
|
|
2017-08-24 |
2017-08-23 |
PS
Planned sale
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Executive Director
|
1,332
-0.7%
23.30
USD 31,036
|
1,332
-0.7%
|
23.30
|
USD 31,036
|
|
|
2017-08-16 |
2017-08-15 |
PS
Planned sale
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Executive Director
|
1,090
-0.5%
24.08
USD 26,247
|
1,090
-0.5%
|
24.08
|
USD 26,247
|
|
|
2017-08-16 |
2017-08-15 |
PS
Planned sale
|
Cole Gregory S
Chief Financial Officer
|
2,350
-4.1%
24.08
USD 56,588
|
2,350
-4.1%
|
24.08
|
USD 56,588
|
|
|
2017-08-16 |
2017-08-15 |
PS
Planned sale
|
MORATIS GEORGE Z
Global Accounting Officer
|
770
-4.5%
24.09
USD 18,549
|
770
-4.5%
|
24.09
|
USD 18,549
|
|
|
2017-08-15 |
2017-08-11 |
PS
Planned sale
|
Cole Gregory S
Chief Financial Officer
|
39,357
-40.6%
23.37
USD 919,631
|
39,357
-40.6%
|
23.37
|
USD 919,631
|
|
|
2017-07-05 |
2017-07-01 |
PS
Planned sale
|
Cole Gregory S
Chief Financial Officer
Officer
|
956
-1.6%
24.33
USD 23,259
|
956
-1.6%
|
24.33
|
USD 23,259
|
|
|
2017-06-16 |
2017-06-16 |
PS
Planned sale
|
Cole Gregory S
Chief Financial Officer
|
13,787
-19.1%
22.73
USD 313,379
|
13,787
-19.1%
|
22.73
|
USD 313,379
|
|
|
2017-06-16 |
2017-06-15 |
PS
Planned sale
|
Cole Gregory S
Chief Financial Officer
|
29,160
-33.4%
22.83
USD 665,723
|
29,160
-33.4%
|
22.83
|
USD 665,723
|
|
|
2017-05-30 |
2017-05-25 |
S
Sale
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Executive Director
|
50,000
-20.1%
22.70
USD 1,135,000
|
50,000
-20.1%
|
22.70
|
USD 1,135,000
|
|
|
2017-05-15 |
2017-05-12 |
S
Sale
|
MORATIS GEORGE Z
Global Accounting Officer
Officer
|
800
-6.0%
21.77
USD 17,419
|
800
-6.0%
|
21.77
|
USD 17,419
|
|
|
2017-05-15 |
2017-05-12 |
S
Sale
|
MORATIS GEORGE Z
Global Accounting Officer
Officer
|
200
-1.5%
21.77
USD 4,354
|
200
-1.5%
|
21.77
|
USD 4,354
|
|
|
2017-05-10 |
2017-05-10 |
S
Sale
|
MORATIS GEORGE Z
Global Accounting Officer
Officer
|
902
-6.3%
21.61
USD 19,492
|
902
-6.3%
|
21.61
|
USD 19,492
|
|
|
2017-02-14 |
2017-01-26 |
S
Sale
|
Welsh, Carson, Anderson & Stowe XI, L.P.
Large shareholder
|
3,926,068
-42.2%
20.23
USD 79,424,356
|
3,926,068
-42.2%
|
20.23
|
USD 79,424,356
|
|
|
2017-02-14 |
2017-01-26 |
S
Sale
|
WCAS Capital Partners IV, L.P.
Large shareholder
|
57,488
-42.2%
20.23
USD 1,162,982
|
57,488
-42.2%
|
20.23
|
USD 1,162,982
|
|
|
2017-02-14 |
2017-01-26 |
S
Sale
|
WCAS MANAGEMENT CORP
Large shareholder
|
3,214
-42.2%
20.23
USD 65,019
|
3,214
-42.2%
|
20.23
|
USD 65,019
|
|
|
2017-02-14 |
2017-01-26 |
S
Sale
|
Welsh, Carson, Anderson & Stowe XI, L.P.
Large shareholder
|
3,926,068
-42.2%
20.23
USD 79,424,356
|
3,926,068
-42.2%
|
20.23
|
USD 79,424,356
|
|
|
2017-02-14 |
2017-01-26 |
S
Sale
|
WCAS Capital Partners IV, L.P.
Large shareholder
|
57,488
-42.2%
20.23
USD 1,162,982
|
57,488
-42.2%
|
20.23
|
USD 1,162,982
|
|
|
2017-01-24 |
2017-01-23 |
PS
Planned sale
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Executive Director
|
561
-0.2%
21.79
USD 12,225
|
561
-0.2%
|
21.79
|
USD 12,225
|
|
|
2017-01-24 |
2017-01-20 |
PS
Planned sale
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Executive Director
|
27,965
-10.1%
21.61
USD 604,324
|
27,965
-10.1%
|
21.61
|
USD 604,324
|
|
|
2017-01-19 |
2017-01-19 |
PS
Planned sale
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Executive Director
|
27,969
-10.1%
21.39
USD 598,257
|
27,969
-10.1%
|
21.39
|
USD 598,257
|
|
|
2017-01-19 |
2017-01-18 |
PS
Planned sale
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Executive Director
|
24,329
-8.9%
21.58
USD 525,010
|
24,329
-8.9%
|
21.58
|
USD 525,010
|
|
|
2017-01-19 |
2017-01-17 |
PS
Planned sale
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Executive Director
|
20,000
-7.4%
21.85
USD 436,996
|
20,000
-7.4%
|
21.85
|
USD 436,996
|
|
|
2016-11-18 |
2016-11-16 |
S
Sale
|
WCAS Capital Partners IV, L.P.
Large shareholder
|
64,674
-32.2%
18.39
USD 1,189,355
|
64,674
-32.2%
|
18.39
|
USD 1,189,355
|
|
|
2016-11-18 |
2016-11-16 |
S
Sale
|
WCAS Capital Partners IV, L.P.
Large shareholder
|
64,674
-32.2%
18.39
USD 1,189,355
|
64,674
-32.2%
|
18.39
|
USD 1,189,355
|
|
|
2016-11-18 |
2016-11-16 |
S
Sale
|
WCAS MANAGEMENT CORP
Large shareholder
|
3,616
-32.2%
18.39
USD 66,498
|
3,616
-32.2%
|
18.39
|
USD 66,498
|
|
|
2016-11-18 |
2016-11-16 |
S
Sale
|
Welsh, Carson, Anderson & Stowe XI, L.P.
Large shareholder
|
4,416,825
-32.2%
18.39
USD 81,225,412
|
4,416,825
-32.2%
|
18.39
|
USD 81,225,412
|
|
|
2016-11-18 |
2016-11-16 |
S
Sale
|
Welsh, Carson, Anderson & Stowe XI, L.P.
Large shareholder
|
4,416,825
-32.2%
18.39
USD 81,225,412
|
4,416,825
-32.2%
|
18.39
|
USD 81,225,412
|
|
|
2016-07-06 |
2016-07-01 |
PS
Planned sale
|
Cole Gregory S
Chief Financial Officer
Officer
|
943
-2.3%
15.70
USD 14,807
|
943
-2.3%
|
15.70
|
USD 14,807
|
|
|
2016-05-24 |
2016-05-21 |
PS
Planned sale
|
Cole Gregory S
Chief Financial Officer
Officer
|
6,465
-19.5%
11.32
USD 73,184
|
6,465
-19.5%
|
11.32
|
USD 73,184
|
|
|
2016-05-10 |
2016-05-07 |
S
Sale
|
Cole Gregory S
Chief Financial Officer
Officer
|
1,702
-11.9%
11.45
USD 19,488
|
1,702
-11.9%
|
11.45
|
USD 19,488
|
|
|
2016-05-10 |
2016-05-07 |
S
Sale
|
MORATIS GEORGE Z
Global Accounting Officer
Officer
|
900
-17.7%
11.40
USD 10,260
|
900
-17.7%
|
11.40
|
USD 10,260
|
|
|
2016-05-05 |
2016-05-05 |
B
Purchase
|
FERRER CARLOS A
Non-Executive Director
|
20,000
+50.8%
11.32
USD 226,400
|
20,000
+50.8%
|
11.32
|
USD 226,400
|
|
|
2016-03-07 |
2016-03-07 |
B
Purchase
|
FERRER CARLOS A
Non-Executive Director
|
38,942
+8850.5%
12.84
USD 500,015
|
38,942
+8850.5%
|
12.84
|
USD 500,015
|
|
|
2015-11-13 |
2015-11-12 |
PS
Planned sale
|
Cole Gregory S
Chief Financial Officer
Officer
|
20,245
-69.0%
19.31
USD 390,931
|
20,245
-69.0%
|
19.31
|
USD 390,931
|
|
|
2015-11-13 |
2015-11-11 |
PS
Planned sale
|
Cole Gregory S
Chief Financial Officer
Officer
|
21,329
-70.1%
20.07
USD 428,073
|
21,329
-70.1%
|
20.07
|
USD 428,073
|
|
|
2015-08-11 |
2015-08-07 |
PS
Planned sale
|
Cole Gregory S
Chief Financial Officer
Officer
|
1,200
-11.7%
21.76
USD 26,112
|
1,200
-11.7%
|
21.76
|
USD 26,112
|
|
|
2015-08-11 |
2015-08-07 |
PS
Planned sale
|
Cole Gregory S
Chief Financial Officer
Officer
|
40,374
-79.7%
20.99
USD 847,450
|
40,374
-79.7%
|
20.99
|
USD 847,450
|
|
|
2015-07-21 |
2015-07-17 |
S
Sale
|
FERRER CARLOS A
Non-Executive Director
|
3,042
-5.0%
22.37
USD 68,050
|
3,042
-5.0%
|
22.37
|
USD 68,050
|
|
|
2015-07-21 |
2015-07-17 |
S
Sale
|
FERRER CARLOS A
Non-Executive Director
|
83,365
-5.0%
22.37
USD 1,864,875
|
83,365
-5.0%
|
22.37
|
USD 1,864,875
|
|
|
2015-07-17 |
2015-07-17 |
S
Sale
|
Welsh, Carson, Anderson & Stowe XI, L.P.
Large shareholder
|
467,293
-3.3%
22.60
USD 10,560,822
|
467,293
-3.3%
|
22.60
|
USD 10,560,822
|
|
|
2015-07-17 |
2015-07-17 |
S
Sale
|
WCAS MANAGEMENT CORP
Large shareholder
|
383
-3.3%
22.60
USD 8,656
|
383
-3.3%
|
22.60
|
USD 8,656
|
|
|
2015-07-17 |
2015-07-17 |
S
Sale
|
WCAS Capital Partners IV, L.P.
Large shareholder
|
6,842
-3.3%
22.60
USD 154,629
|
6,842
-3.3%
|
22.60
|
USD 154,629
|
|
|
2015-07-17 |
2015-07-17 |
S
Sale
|
WCAS Capital Partners IV, L.P.
Large shareholder
|
6,842
-3.3%
22.60
USD 154,629
|
6,842
-3.3%
|
22.60
|
USD 154,629
|
|
|
2015-07-17 |
2015-07-17 |
S
Sale
|
Welsh, Carson, Anderson & Stowe XI, L.P.
Large shareholder
|
467,293
-3.3%
22.60
USD 10,560,822
|
467,293
-3.3%
|
22.60
|
USD 10,560,822
|
|
|
2015-07-15 |
2015-07-13 |
S
Sale
|
FERRER CARLOS A
Non-Executive Director
|
20,279
-25.0%
22.37
USD 453,641
|
20,279
-25.0%
|
22.37
|
USD 453,641
|
|
|
2015-07-15 |
2015-07-13 |
S
Sale
|
FERRER CARLOS A
Non-Executive Director
|
555,769
-25.0%
22.37
USD 12,432,553
|
555,769
-25.0%
|
22.37
|
USD 12,432,553
|
|
|
2015-07-13 |
2015-07-13 |
S
Sale
|
WCAS MANAGEMENT CORP
Large shareholder
|
2,551
-18.0%
22.60
USD 57,653
|
2,551
-18.0%
|
22.60
|
USD 57,653
|
|
|
2015-07-13 |
2015-07-13 |
S
Sale
|
WCAS Capital Partners IV, L.P.
Large shareholder
|
45,616
-18.0%
22.60
USD 1,030,922
|
45,616
-18.0%
|
22.60
|
USD 1,030,922
|
|
|
2015-07-13 |
2015-07-13 |
S
Sale
|
Welsh, Carson, Anderson & Stowe XI, L.P.
Large shareholder
|
3,115,287
-18.0%
22.60
USD 70,405,486
|
3,115,287
-18.0%
|
22.60
|
USD 70,405,486
|
|
|
2015-07-13 |
2015-07-13 |
S
Sale
|
WCAS Capital Partners IV, L.P.
Large shareholder
|
45,616
-18.0%
22.60
USD 1,030,922
|
45,616
-18.0%
|
22.60
|
USD 1,030,922
|
|
|
2015-07-13 |
2015-07-13 |
S
Sale
|
Welsh, Carson, Anderson & Stowe XI, L.P.
Large shareholder
|
3,115,287
-18.0%
22.60
USD 70,405,486
|
3,115,287
-18.0%
|
22.60
|
USD 70,405,486
|
|
|
2015-06-29 |
2015-06-29 |
PS
Planned sale
|
Cole Gregory S
Chief Financial Officer
Officer
|
8,848
-96.6%
24.05
USD 212,794
|
8,848
-96.6%
|
24.05
|
USD 212,794
|
|
|
2015-06-29 |
2015-06-26 |
PS
Planned sale
|
Cole Gregory S
Chief Financial Officer
Officer
|
15,300
-98.0%
24.01
USD 367,353
|
15,300
-98.0%
|
24.01
|
USD 367,353
|
|
|
2015-06-29 |
2015-06-25 |
PS
Planned sale
|
Cole Gregory S
Chief Financial Officer
Officer
|
14,841
-98.0%
24.55
USD 364,347
|
14,841
-98.0%
|
24.55
|
USD 364,347
|
|
|
2015-06-24 |
2015-06-24 |
PS
Planned sale
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Executive Director
|
6,459
-2.7%
24.27
USD 156,760
|
6,459
-2.7%
|
24.27
|
USD 156,760
|
|
|
2015-06-24 |
2015-06-24 |
PS
Planned sale
|
Cole Gregory S
Chief Financial Officer
Officer
|
8,034
-96.3%
24.27
USD 194,985
|
8,034
-96.3%
|
24.27
|
USD 194,985
|
|
|
2015-06-24 |
2015-06-23 |
PS
Planned sale
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Executive Director
|
10,668
-4.3%
24.89
USD 265,527
|
10,668
-4.3%
|
24.89
|
USD 265,527
|
|
|
2015-06-24 |
2015-06-23 |
PS
Planned sale
|
Cole Gregory S
Chief Financial Officer
Officer
|
10,711
-97.2%
24.91
USD 266,811
|
10,711
-97.2%
|
24.91
|
USD 266,811
|
|
|
2015-06-24 |
2015-06-22 |
PS
Planned sale
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Executive Director
|
7,210
-3.0%
25.36
USD 182,846
|
7,210
-3.0%
|
25.36
|
USD 182,846
|
|
|
2015-06-24 |
2015-06-22 |
PS
Planned sale
|
Cole Gregory S
Chief Financial Officer
Officer
|
8,639
-96.6%
25.36
USD 219,085
|
8,639
-96.6%
|
25.36
|
USD 219,085
|
|
|
2015-06-23 |
2015-06-19 |
PS
Planned sale
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Executive Director
|
18,165
-7.1%
24.94
USD 453,035
|
18,165
-7.1%
|
24.94
|
USD 453,035
|
|
|
2015-06-18 |
2015-06-18 |
PS
Planned sale
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Executive Director
|
24,900
-11.6%
24.80
USD 617,520
|
24,900
-11.6%
|
24.80
|
USD 617,520
|
|
|
2015-06-18 |
2015-06-17 |
PS
Planned sale
|
KOSTUIK JOHN PHILIP MD
Chief Medical Officer
Executive Director
|
10,109
-4.5%
24.28
USD 245,447
|
10,109
-4.5%
|
24.28
|
USD 245,447
|
|
|
2015-06-05 |
2015-06-03 |
S
Sale
|
Cole Gregory S
Chief Financial Officer
Officer
|
13,350
-97.7%
24.57
USD 328,010
|
13,350
-97.7%
|
24.57
|
USD 328,010
|
|
|
2015-02-13 |
2015-02-12 |
S
Sale
|
BRODNAX BRETT
Non-Executive Director
|
5,564
-17.1%
19.73
USD 109,778
|
5,564
-17.1%
|
19.73
|
USD 109,778
|
|
|
2015-02-10 |
2015-02-09 |
S
Sale
|
WCAS MANAGEMENT CORP
Large shareholder
|
728
-4.9%
18.75
USD 13,650
|
728
-4.9%
|
18.75
|
USD 13,650
|
|
|
2015-02-10 |
2015-02-09 |
S
Sale
|
WCAS Capital Partners IV, L.P.
Large shareholder
|
13,031
-4.9%
18.75
USD 244,331
|
13,031
-4.9%
|
18.75
|
USD 244,331
|
|
|
2015-02-10 |
2015-02-09 |
S
Sale
|
Welsh, Carson, Anderson & Stowe XI, L.P.
Large shareholder
|
889,990
-4.9%
18.75
USD 16,687,313
|
889,990
-4.9%
|
18.75
|
USD 16,687,313
|
|
|
2015-02-10 |
2015-02-09 |
S
Sale
|
Welsh, Carson, Anderson & Stowe XI, L.P.
Large shareholder
|
889,990
-4.9%
18.75
USD 16,687,313
|
889,990
-4.9%
|
18.75
|
USD 16,687,313
|
|
|
2015-02-10 |
2015-02-09 |
S
Sale
|
WCAS Capital Partners IV, L.P.
Large shareholder
|
13,031
-4.9%
18.75
USD 244,331
|
13,031
-4.9%
|
18.75
|
USD 244,331
|
|
